Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05895929 · ClinicalTrials.gov registry record · Early Phase 1
The Role of IL5 in Epithelial Cell Integrity
A Early Phase 1 study of Chronic Rhinosinusitis With Nasal Polyps and Chronic Rhinosinusitis (Diagnosis), sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 8
- Enrollment target
- 2
- Study locations
NCT05895929: Recruiting Early Phase 1 study of Chronic Rhinosinusitis With Nasal Polyps and Chronic Rhinosinusitis (Diagnosis), sponsored by Johns Hopkins University.
NCT05895929 is a Early Phase 1 study of Chronic Rhinosinusitis With Nasal Polyps and Chronic Rhinosinusitis (Diagnosis) that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 8 participants, below the 142-participant average among 11 other Chronic Rhinosinusitis With Nasal Polyps trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05895929, a Early Phase 1 study of Chronic Rhinosinusitis With Nasal Polyps and Chronic Rhinosinusitis (Diagnosis), is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 8 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this laboratory study is the examine the effect of mepolizumab drug on the health and function of the cells lining the human nasal airways in vitro cell culture derived from patients with chronic rhinosinusitis with nasal polyposis. The main questions the study aims to study are: 1. To see what mepolizumab does to suppress inflammation of the human cells. 2. To see what mepolizumab does to maintain barrier integrity of epithelial cells
Primary Outcome
IL8 cytokine mRNA and protein expression
Conditions Studied
Interventions
- DRUG Mepolizumab
Study Locations (2)
Maryland
- Johns Hopkins Bayview Medical Center - Baltimore
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2023-09-05 |
| Est. Completion | 2026-06 |
| Phase | Early Phase 1 |
What NCT05895929 shows while recruiting
NCT05895929 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 142-participant average among 11 other Chronic Rhinosinusitis With Nasal Polyps trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Chronic Rhinosinusitis With Nasal Polyps appearing as the primary indexed condition, and to 1 intervention - of which Mepolizumab is the first listed.
NCT05895929 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05895929 about?
NCT05895929 is a clinical study titled "The Role of IL5 in Epithelial Cell Integrity". The goal of this laboratory study is the examine the effect of mepolizumab drug on the health and function of the cells lining the human nasal airways in vitro cell culture derived from patients with chronic rhinosinusitis with nasal polyposis. The main questions the study aims to study are: 1. To ...
What is the current status of trial NCT05895929?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 8 participants. The study started on 2023-09-05. Estimated completion is 2026-06.
What conditions does trial NCT05895929 study?
This clinical trial studies the following conditions: Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis (Diagnosis).
What interventions are being tested in trial NCT05895929?
The interventions under investigation include: Mepolizumab (DRUG).
Who is sponsoring clinical trial NCT05895929?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05895929 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Rhinosinusitis With Nasal Polyps
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05895929's enrollment target sits among peer trials
8 12th of 11 the lowest of 11 other Chronic Rhinosinusitis With Nasal Polyps trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Rhinosinusitis With Nasal Polyps trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
RECRUITING · Phase 3
-
Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Study
RECRUITING · Phase 2
-
A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab
RECRUITING · Phase 3
-
3D Printing to Improve Nasal Irrigation Outcome
RECRUITING · NA
-
Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis
RECRUITING
-
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI